Seaport Therapeutics is a clinical-stage therapeutics company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. The Company has a proven strategy of advancing clinically validated mechanisms previously held back by limitations that are overcome with its proprietary GlyphTM technology platform. All the therapeutic candidates in its pipeline of first and best-in-class medicines are based on the Glyph platform, which is uniquely designed to enable oral bioavailability, bypass first-pass metabolism and reduce hepatotoxicity and other side effects. Seaport is led by an experienced team that invented and advanced important neuropsychiatric medicines and are guided by an extensive network of renowned scientists, clinicians and key opinion leaders. We are seeking an experienced scientist to take a key role in advancing preclinical discovery of its Glyph prodrug platform across a range of indications. The ideal candidate will have a roll up your sleeve’s mentality, contributing to a bioanalytical program to rigorously elucidate the functionality of a novel lipid prodrug platform and contribute to the selection of a program’s development candidates. This scientist may contribute beyond bioanalysis, i.e. expanding DMPK and ADME functions. The ideal candidate will embrace a collaborative, innovative culture that embodies our values of service to patients impacted by mental health conditions, with a “we own it” mentality, demonstrating entrepreneurial spirit and technical excellence while fostering teamwork and continuous improvement. This position is based in Boston’s Seaport area and will be an in-office role 5 days a week and report to the Associate Director, Bioanalytical Sciences.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior